Potential changes to the FDA approach to biosimilars have a global impact
| العنوان: | Potential changes to the FDA approach to biosimilars have a global impact |
|---|---|
| المؤلفون: | Pekka Kurki |
| المصدر: | Generics and Biosimilars Initiative Journal. 7:53-55 |
| بيانات النشر: | Pro Pharma Communications International, 2018. |
| سنة النشر: | 2018 |
| مصطلحات موضوعية: | 030203 arthritis & rheumatology, 03 medical and health sciences, 0302 clinical medicine, Risk analysis (engineering), 030220 oncology & carcinogenesis, Drug Guides, Biosimilar, Pharmacy, Business, Interchangeability |
| تدمد: | 2033-6772 2033-6403 |
| DOI: | 10.5639/gabij.2018.0702.011 |
| URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::97716e511b25643f7a2686f19efe8ef9 https://doi.org/10.5639/gabij.2018.0702.011 |
| رقم الانضمام: | edsair.doi...........97716e511b25643f7a2686f19efe8ef9 |
| قاعدة البيانات: | OpenAIRE |
| تدمد: | 20336772 20336403 |
|---|---|
| DOI: | 10.5639/gabij.2018.0702.011 |